Research, Innovation, and Society Research impact & outcomesSpin-Off
Spin-Off
Academic Spin-offs List
Year of Incorporation: 2017
Activity Code (ATECO): 72.11.00 – Experimental research and development in the field of biotechnology
Target Sector: Human Life Sciences
Registered as an Innovative Start-up since: 2020
MCK Therapeutics is a biotechnology company focused on the research and development of innovative solutions and molecules targeting potassium channels. Through its activities, the company aims to support pharmaceutical firms in bringing the results of research and development phases to production and the market.
Its focus includes new compounds and small molecules, with special attention to whole and recombinant antibodies. The spin-off's next objective is the production of monoclonal and engineered antibodies for cancer diagnosis and therapy.
Shareholders / Founders
Annarosa Arcangeli and Giovanni Navalesi
Contacts
Via Madonna del Piano, 6 – Sesto Fiorentino (Florence), Italy
Tel: +39 329 8571922